- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Procaps Group, S.A. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 09.04. | Procaps Group, S.A.: Procaps Group Secures $130 Million in Equity Investment and Completes Comprehensive Debt Restructuring, as New Investors Take Over Strategic Leadership | 63 | GlobeNewswire (Europe) | New Investors Take Over the Strategic Leadership as Headquarters Move to Bogotá, Marking the Start of a New Chapter of Growth, Execution, and Transformation under Enhanced Governance Company Accelerates... ► Artikel lesen | |
| 09.04. | Procaps Group, S.A. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 25.03. | Procaps Group, S.A. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 06.03. | Procaps Group, S.A. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 19.02. | Procaps Group, S.A. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| PROCAPS GROUP Aktie jetzt für 0€ handeln | |||||
| 17.02. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 17.02.2025 | 1.250 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 17.02.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 17.02.2025ISIN NameCA00208E3077 ATI... ► Artikel lesen | |
| 04.02. | Nasdaq delists Colombia's Procaps Group due to financial shortfalls | 1 | iNVEZZ.com | ||
| 04.02. | XFRA 9X1: AUSSETZUNG/SUSPENSION | 313 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILPROCAPS GRP S.A.... ► Artikel lesen | |
| 03.02. | Procaps Group, S.A.: Procaps Group Receives Delisting Notice From Nasdaq | 362 | GlobeNewswire (Europe) | MIAMI and BARRANQUILLA, Columbia, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and pharmaceutical services... ► Artikel lesen | |
| 03.02. | Procaps Group, S.A. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 16.01. | Procaps Group, S.A. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 03.01. | Procaps Group, S.A.: Procaps Group Receives Additional Delinquency Letter | 290 | GlobeNewswire (Europe) | MIAMI and BARRANQUILLA, Columbia, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and pharmaceutical services... ► Artikel lesen | |
| 31.12.24 | Procaps Group, S.A. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 20.12.24 | Procaps Group announces newly appointed board members, CFO transition | 2 | Seeking Alpha | ||
| 20.12.24 | Procaps Group, S.A.: Procaps Group Announces Key Shareholder and Board Decisions, Committee Restructuring, and Leadership Updates | 285 | GlobeNewswire (Europe) | MIAMI and BARRANQUILLA, Colombia, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and pharmaceutical services... ► Artikel lesen | |
| 20.12.24 | Procaps Group, S.A. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 03.12.24 | Procaps announces financing, shareholders agreement and board updates | 3 | Seeking Alpha | ||
| 03.12.24 | Procaps Group, S.A.: Procaps Group Announces Financing, Shareholders Agreement and Board Updates | 202 | GlobeNewswire (Europe) | MIAMI and BARRANQUILLA, Colombia, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and pharmaceutical services... ► Artikel lesen | |
| 29.11.24 | Procaps Group, S.A. - 6-K, Report of foreign issuer | - | SEC Filings |
Seite:
1 2 Weiter >>
25 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 4,485 | -0,66 % | BRISANTE Meldung setzt Aurora Cannabis Aktionäre unter Zugzwang. Bitte reagieren Sie jetzt sofort! | ||
| CANOPY GROWTH | 1,258 | -0,32 % | Starke Zahlen, Aktie steigt: Nicht Canopy Growth: Diese Cannabis-Aktie gibt es jetzt umsonst! | © Foto: Dall-EDas Cannabisunternehmen Cronos hat am Donnerstagmittag starke Quartalszahlen vorgelegt - und im Unterschied zu Canopy Growth einen Nettogewinn erzielt.Innerhalb der Cannabis-Branche gilt... ► Artikel lesen | |
| TILRAY BRANDS | 0,395 | +0,53 % | Tilray Brands, Inc.: Shock Top: A Bold Rebrand for a Craft Beer Icon | PORTLAND, Ore., May 08, 2025 (GLOBE NEWSWIRE) -- Shock Top, a craft beer icon and brand by Tilray Brands, Inc. company (NASDAQ: TLRY and TSX: TLRY), known for its bold flavors and unfiltered wheat... ► Artikel lesen | |
| TEVA | 15,250 | +0,66 % | Teva Pharmaceutical: Teva's 2024 Healthy Future Report Highlights Sustainability Progress, Including Surpassed Targets Linked to Financial Strategy | TEL AVIV, IL / ACCESS Newswire / May 13, 2025 / Teva PharmaceuticalThe Company achieved a 29% reduction in absolute scope 1 and 2 greenhouse gas emissions from 2019 levels, surpassing its target of... ► Artikel lesen | |
| VERTEX PHARMACEUTICALS | 373,00 | -1,05 % | VERTEX PHARMACEUTICALS INC / MA - 8-K, Current Report | ||
| ARZNEIWERK AG VIDA | 0,620 | +6,90 % | PTA-AFR: Arzneiwerk AG VIDA: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114-117 WpHG | DJ PTA-AFR: Arzneiwerk AG VIDA: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114-117 WpHG
Vorabbekanntmachung Finanzberichte gemäß ---- 114-117 WpHG
Arzneiwerk... ► Artikel lesen | |
| CRONOS GROUP | 1,901 | +2,76 % | Cronos Group Inc.: Cronos Group Reports 2025 First Quarter Results | Net revenue in Q1 2025 increased by 28% year-over-year, 33% year-over-year net revenue growth on a constant currency basis PEACE NATURALS® retained its position as the number one cannabis brand in... ► Artikel lesen | |
| VIATRIS | 7,654 | +1,70 % | Viatris-Aktie mit Kursverlusten (7,55567 €) | Die Aktie von Viatris notiert am Mittwoch etwas leichter. Der jüngste Kurs betrug 8,47 US-Dollar. Heute hat sich am US-amerikanischen Aktienmarkt die Viatris-Aktie zwischenzeitlich um 3,64 Prozent verbilligt.... ► Artikel lesen | |
| INCYTE | 54,60 | -0,29 % | Aktie von Incyte: Kurs nur geringfügig im Minus (52,6904 €) | Die Wertschätzung für den Anteilsschein von Incyte hat sich am Aktienmarkt heute kaum geändert. Die Aktie notiert aktuell bei 59,37 US-Dollar. Die Wertschätzung der Investoren für die Aktie von Incyte... ► Artikel lesen | |
| BAUSCH HEALTH | 4,088 | 0,00 % | Bausch Health Companies Inc: Bausch Health Announces 2025 Annual Meeting of Shareholder Results | LAVAL, QC / ACCESS Newswire / May 14, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced the election of the 10 directors nominated at its 2025 annual meeting of shareholders ("Annual... ► Artikel lesen | |
| IONIS PHARMACEUTICALS | 28,870 | -0,03 % | Ionis Pharmaceuticals, Inc.: Ionis expands partnership with Sobi to include olezarsen commercialization outside the U.S. | - Agreement enables olezarsen to reach people living with conditions associated with elevated triglycerides across the world - - Ionis will continue to independently commercialize TRYNGOLZA (olezarsen)... ► Artikel lesen | |
| CRESCO LABS | 0,611 | -3,78 % | Cresco Labs slips after delaying Q1 earnings call | ||
| ALNYLAM PHARMACEUTICALS | 235,40 | -0,30 % | Stifel maintains $345 target on Alnylam stock, optimistic on Amvuttra | ||
| NEKTAR THERAPEUTICS | 0,621 | -2,51 % | Nektar Therapeutics Q1 Loss Increases, Misses Estimates | WASHINGTON (dpa-AFX) - Nektar Therapeutics (NKTR) released Loss for its first quarter that increased from last year and missed the Street estimates.The company's bottom line came in at -$50.88... ► Artikel lesen | |
| ORAMED PHARMACEUTICALS | 1,952 | -3,63 % | Oramed Pharmaceuticals Inc.: Oramed Pharmaceuticals Announces $36.9 Million Investment and Strategic Collaboration with Alpha Tau Medical | Oramed leverages its strategic capital markets expertise to support Alpha Tau's breakthrough cancer therapy technology
Accelerating multiple late-stage cancer therapies... ► Artikel lesen |
Das Unternehmen PROCAPS GROUP SA kann der Branche Pharma zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 1,340 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PROCAPS GROUP SA finden Sie auf Wallstreet Online.